Chevy Chase Trust Holdings, Inc. Novo Nordisk A S Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q4 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 3,424 shares of NVO stock, worth $287,307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,424
Previous 3,791
9.68%
Holding current value
$287,307
Previous $451,000
34.81%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,868Shares Held
323MCall Options Held
5.57MPut Options Held
7.6M-
Jennison Associates LLC19.9MShares$1.67 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.21 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.2 Billion0.14% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.09 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.06 Billion0.44% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $189B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...